{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:30:56Z","timestamp":1720708256247},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.medcli.2012.09.042","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T15:46:58Z","timestamp":1358524018000},"page":"382-386","source":"Crossref","is-referenced-by-count":10,"title":["Correlaci\u00f3n entre las concentraciones plasm\u00e1ticas de homociste\u00edna y la polineuropat\u00eda diab\u00e9tica evaluada con la prueba del monofilamento de Semmes-Weinstein en pacientes con diabetes tipo 2"],"prefix":"10.1016","volume":"141","author":[{"given":"Mercedes","family":"Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Folgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 T.","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Mart\u00ednez-Herv\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Priego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Ascaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2012.09.042_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mcna.2008.12.001","article-title":"Peripheral neuropathy","volume":"93","author":"Pascuzzi","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.medcli.2012.09.042_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archinte.158.2.157","article-title":"Practical criteria for screening patients at high risk for diabetic foot ulceration","volume":"158","author":"Lavery","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2012.09.042_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diab.37.4.476","article-title":"Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT)","volume":"37","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.medcli.2012.09.042_bib0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1211\/jpp.61.09.0002","article-title":"Diabetic neuropathy: Therapies on the horizon","volume":"61","author":"Mahmood","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.medcli.2012.09.042_bib0025","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2337\/dc08-0278","article-title":"Prevalence and risk factors for neuropathy in a Canadian community","volume":"31","author":"Bruce","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medcli.2012.09.042_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1464-5491.2001.00445.x","article-title":"Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus","volume":"18","author":"Ambrosch","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.medcli.2012.09.042_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdiacomp.2003.12.003","article-title":"Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2","volume":"19","author":"De Luis","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.medcli.2012.09.042_bib0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1566-0702(00)00262-9","article-title":"Increasing homocysteine levels and diabetic autonomic neuropathy","volume":"87","author":"Cohen","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.medcli.2012.09.042_bib0045","first-page":"297","article-title":"Plasma homocysteine and microvascular complications in type 1 diabetes","volume":"10","author":"Vaccaro","year":"2000","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.medcli.2012.09.042_bib0050","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","article-title":"Vascular oxidant stress and inflammation in hyperhomocysteinemia","volume":"9","author":"Papatheodorou","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.medcli.2012.09.042_bib0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.medcli.2008.11.032","article-title":"Homociste\u00edna en la cl\u00ednica humana","volume":"133","author":"Aguirre Errasti","year":"2009","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.09.042_bib0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/znc-1995-9-1017","article-title":"Homocysteine-induced oxidative damage: Mechanisms and possible roles in neurodegenerative and atherogenic processes","volume":"50","author":"Schlussel","year":"1995","journal-title":"Z Naturforsch"},{"key":"10.1016\/j.medcli.2012.09.042_bib0065","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jvs.2009.05.017","article-title":"The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy","volume":"50","author":"Feng","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.medcli.2012.09.042_bib0070","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s001250050829","article-title":"Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study","volume":"40","author":"De Sonnaville","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.medcli.2012.09.042_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.medcli.2009.02.022","article-title":"Patr\u00f3n diferencial de homociste\u00edna en pacientes con enfermedad arterial perif\u00e9rica","volume":"134","author":"Burgos","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.09.042_bib0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2012.09.042_bib0085","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2006.05.049","article-title":"The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"48","author":"Allison","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2012.09.042_bib0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.medcli.2010.07.009","article-title":"Valor pron\u00f3stico de marcadores inflamatorios y perfil lip\u00eddico en pacientes con claudicaci\u00f3n intermitente. Estudio piloto","volume":"136","author":"Vega de Cerriga","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.09.042_bib0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diabres.2011.03.020","article-title":"Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes","volume":"93","author":"Jianbo","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.medcli.2012.09.042_bib0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dmrr.1061","article-title":"Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus","volume":"26","author":"Gonz\u00e1lez","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.medcli.2012.09.042_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc09-0606","article-title":"Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy","volume":"33","author":"Wile","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medcli.2012.09.042_bib0110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/ATVBAHA.108.178228","article-title":"Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate","volume":"29","author":"Taskinen","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.medcli.2012.09.042_bib0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10557-009-6188-1","article-title":"Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine","volume":"23","author":"Lever","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.medcli.2012.09.042_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","article-title":"Homocysteine metabolism and its relation to health and disease","volume":"36","author":"Williams","year":"2010","journal-title":"Biofactors"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312009657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312009657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T21:47:33Z","timestamp":1714859253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775312009657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0025775312009657"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2012.09.042","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}